Advances in Tumor Immunology and Immunotherapy [[electronic resource] /] / edited by Joseph D. Rosenblatt, Eckhard R. Podack, Glen N. Barber, Augusto Ochoa |
Edizione | [1st ed. 2014.] |
Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Springer, , 2014 |
Descrizione fisica | 1 online resource (369 p.) |
Disciplina |
614.5999
616.994079 |
Collana | Current Cancer Research |
Soggetto topico |
Cancer research
Pharmacology Cancer Research Pharmacology/Toxicology |
ISBN | 1-4614-8809-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Contents; Introduction; Part IImmune Activation, Suppression and Manipulation of the Immune Antitumor Response; Myeloid-Derived Suppressor Cells in Cancer; 1 Introduction; 2 Preclinical Data; 2.1 Phenotype; 2.2 Expansion and Activation of MDSCs in Tumor Models; 2.3 Mechanisms of Immunosuppression of MDSCs in Cancer; 2.3.1 Metabolism of l -Arginine; 2.3.2 ROS and Peroxynitrite; 3 Clinical Data; 4 Pharmacologic Modulation of MDSCs; 5 Conclusions; References; The Role of B Cells in Shaping the Antitumor Immune Response; 1 Introduction; 2 B Cells and Antitumor Immunity
3 Mechanisms of B Cell Modulation of Immune Response3.1 Be1 and Be2 Differentiation and Skewing of T Cell Response; 3.2 B Cells and Antigen Presentation; 3.3 B Cells and Expansion of Tregs; 3.4 B10 Cells and Immune Suppression; 3.5 Other Breg Subsets and Role of TGF-β; 3.6 B Cells and Chronic Inflammation; 4 Effects of B Cell Depletion on Antitumor Immunity; 5 B Cell Infiltration in Human Tumors; 6 Conclusions; References; Heat-Shock Protein-Based Cancer Immunotherapy; 1 Heat-Shock Proteins, Sterile Inflammation, and Immunosurveillance; 2 Autologous Purified HSP Vaccines 3 Allogeneic Cell-Based HSP Vaccines4 Recombinant and Nucleic Acid-Based HSP Vaccines; 5 Conclusions Based on Clinical Evidence; References; Activation of NK Cell Responses and Immunotherapy of Cancer; 1 Background and History of NK Cells; 2 NK Cell Activation; 3 NK Cells and Cancer; 4 Activated NK Cells as a Cancer Immunotherapy; 5 NK Cells and Other Immunotherapeutic Approaches; 6 Conclusion; References; Induction of Tumor Immunity by Targeted Inhibition of Nonsense-Mediated mRNA Decay; 1 Introduction; 2 Nonsense-Mediated mRNA Decay: A Primer; 2.1 Physiological Roles of NMD 2.2 Role of NMD in Cancer3 Tumor-Targeted NMD Inhibition to Express New Antigens in Disseminated Tumor Lesions; 3.1 The Concept and Rationale; 3.2 Preclinical Proof-of-Concept Studies in Murine Tumor Models; 4 Conclusions and Future Directions; 4.1 Cytotoxic Therapy or Immunotherapy?; 4.2 What If?; References; Employing T Cell Homeostasis as an Antitumor Strategy; 1 Introduction; 2 Homeostasis of T Lymphocytes; 3 Lymphopenia-Induced T Cell Proliferation; 4 Lymphopenia-Induced Pathologies; 5 Lymphopenia-Induced Antitumor Immune Responses; 6 Clinical Evidence/The Human Model 7 Adoptive Immunotherapy of Cancer8 Vaccine Augmentation; 9 Lymphopenia-Induced Changes in T reg Percentages; 10 The Dose Makes the Poison; 11 Conclusion; References; Adoptive Cell Therapy of Systemic Metastases Using erbB-2-Specific T Cells Redirected with a Chimeric Antibody-Based Receptor; 1 Introduction; 2 Results and Discussion; 2.1 Phenotypic and Functional Profile of the erbB-2-Specific CAR in Transgenic Mice; 2.2 Naïve TgN29 Mice Reject Renca-erbB-2 Tumors; 2.3 Adoptive Transfer of Naïve Lymphocytes from TgN29 Mice Extends the Survival of Mice with Systemic Lung Metastases 2.4 Redirected Allogeneic T Cells (Allo-T-Bodies) as Potential Universal Donors |
Record Nr. | UNINA-9910300096003321 |
New York, NY : , : Springer New York : , : Imprint : Springer, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer and inflammation [[electronic resource] ] : [Symposium on Cancer and Inflammation, held at the Novartis Foundation, London, 12-14 November 2002 / / editors, Derek J. Chadwick (organizer) and Jamie A. Goode] |
Pubbl/distr/stampa | Chichester, U.K. ; ; Hoboken, N.J., : John Wiley & Sons, 2004 |
Descrizione fisica | 1 online resource (292 p.) |
Disciplina |
571.978
616.99/4079 616.994079 |
Altri autori (Persone) |
ChadwickDerek
GoodeJamie |
Collana | Novartis Foundation symposium |
Soggetto topico |
Cancer - Immunological aspects
Inflammation |
Soggetto genere / forma | Electronic books. |
ISBN |
1-280-27061-6
9786610270613 0-470-66758-3 0-470-85672-6 0-470-85673-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CANCER AND INFLAMMATION; Contents; Participants; Chair's introduction; Inflammation and cancer: an epidemiological perspective; Discussion; Chemokine-based pathogenetic mechanisms in cancer; Discussion; General discussion I; Anti-TNFa therapy of rheumatoid arthritis: what can we learn about chronic disease?; Discussion; How do chemokine/chemokine receptor activations affect tumorigenesis?; Discussion; Proinflammatory cytokines, immune response and tumour progression; Discussion; General discussion II; Lymphangiogenesis and tumour metastasis; Discussion
Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytesDiscussion; The influence of CD25(+) cells on the generation of immunity to tumour cell-lines in mice; Discussion; Macrophages: modulators of breast cancer progression; Discussion; Chemokines: angiogenesis and metastases in lung cancer; Discussion; Macrophage infiltration and angiogenesis in human malignancy; Discussion; The role of inflammation in tumour growth and tumour suppression; Discussion; Cyclooxygenase 2: from inflammation to carcinogenesis DiscussionThe inflammatory cytokine network of epithelial cancer: therapeutic implications; Discussion; In vivo manipulation of DC migration and activation to elicit anti-tumour immunity; Discussion; Final general discussion; Concluding remarks; Index of contributors; Subject index |
Record Nr. | UNINA-9910143478203321 |
Chichester, U.K. ; ; Hoboken, N.J., : John Wiley & Sons, 2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer and inflammation [[electronic resource] ] : [Symposium on Cancer and Inflammation, held at the Novartis Foundation, London, 12-14 November 2002 / / editors, Derek J. Chadwick (organizer) and Jamie A. Goode] |
Pubbl/distr/stampa | Chichester, U.K. ; ; Hoboken, N.J., : John Wiley & Sons, 2004 |
Descrizione fisica | 1 online resource (292 p.) |
Disciplina |
571.978
616.99/4079 616.994079 |
Altri autori (Persone) |
ChadwickDerek
GoodeJamie |
Collana | Novartis Foundation symposium |
Soggetto topico |
Cancer - Immunological aspects
Inflammation |
ISBN |
1-280-27061-6
9786610270613 0-470-66758-3 0-470-85672-6 0-470-85673-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CANCER AND INFLAMMATION; Contents; Participants; Chair's introduction; Inflammation and cancer: an epidemiological perspective; Discussion; Chemokine-based pathogenetic mechanisms in cancer; Discussion; General discussion I; Anti-TNFa therapy of rheumatoid arthritis: what can we learn about chronic disease?; Discussion; How do chemokine/chemokine receptor activations affect tumorigenesis?; Discussion; Proinflammatory cytokines, immune response and tumour progression; Discussion; General discussion II; Lymphangiogenesis and tumour metastasis; Discussion
Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytesDiscussion; The influence of CD25(+) cells on the generation of immunity to tumour cell-lines in mice; Discussion; Macrophages: modulators of breast cancer progression; Discussion; Chemokines: angiogenesis and metastases in lung cancer; Discussion; Macrophage infiltration and angiogenesis in human malignancy; Discussion; The role of inflammation in tumour growth and tumour suppression; Discussion; Cyclooxygenase 2: from inflammation to carcinogenesis DiscussionThe inflammatory cytokine network of epithelial cancer: therapeutic implications; Discussion; In vivo manipulation of DC migration and activation to elicit anti-tumour immunity; Discussion; Final general discussion; Concluding remarks; Index of contributors; Subject index |
Record Nr. | UNINA-9910677082103321 |
Chichester, U.K. ; ; Hoboken, N.J., : John Wiley & Sons, 2004 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer Immunology [[electronic resource] ] : Bench to Bedside Immunotherapy of Cancers / / edited by Nima Rezaei |
Edizione | [2nd ed. 2021.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 |
Descrizione fisica | 1 online resource |
Disciplina | 616.994079 |
Soggetto topico |
Oncology
Immunology Internal medicine Internal Medicine |
ISBN | 3-030-50287-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Frontiers in Cancer Immunotherapy -- Novel Strategy of Cancer Immunotherapy: Spiraling Up -- Novel Prognostic Biomarkers for Personalized Cancer Treatments -- Tumor Antigen and Epitope Identification for Pre-Clinical and Clinical Evaluation -- Strategies to Target Tumor Immunesuppression -- Immune Modulation of Drugs in Prevention and Treatment of Cancers -- Overcoming Immune Tolerance With Immune Checkpoint Blockade -- Gene therapy and Virus-Based Cancer Vaccines -- Cancer Stem Cells: Biology and Potential therapeutic Applications -- Hematopoietic Stem Cell Transplantation and Lymphodepletion in Treatment of Cancers -- Combination of Chemotherapy and Cytokine Therapy in Treatment of Cancers -- T Cell Immunotherapy: From Synthetic Biology to Clinical Practice -- Role of Gamma-Delta T Lymphocytes in Cancer Immunosurveillance and Immunotherapy -- Adoptive T Cell therapy: Optimizing Chemokine Receptor-Mediated Homing of T Cells in Cancer Immunotherapy -- Cellular therapy of Cancer With B Effector Cells -- Monoclonal Antibodies for Treatment of Cancers -- Pattern Recognition Receptors in Cancers and Immunotherapy by Triggering or Targeting of Toll Like Receptors Pathway -- Recent Advances in the Use of NK Cells Against Cancer -- Dendritic Cell Vaccines for Cancer Therapy: Fundamentals and Clinical Trials -- Tumor Associated Macrophages and iNOS in Cancer Immunotherapy -- Photodynamic therapy and Anti-Tumor Immune Response -- Polarization of Tumor Milieu: Therapeutic Implications -- Immunotherapies Targeting 5T4 Oncofoetal Glycoprotein -- Immune Monitoring During Clinical Development of Anti-CTLA-4 Antibody Therapy -- PD-1 Blockade in Cancer Therapy -- New Advances in Radioimmunotherapy for the Treatment of Cancers -- Psychoneuroendocrinoimmunotherapy of Cancers -- Ethical Considerations in Cancer Immunotherapy. |
Record Nr. | UNINA-9910483046003321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Cancer Immunology [[electronic resource] ] : A Translational Medicine Context / / edited by Nima Rezaei |
Edizione | [2nd ed. 2020.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (XVI, 802 p. 150 illus., 143 illus. in color.) |
Disciplina | 616.994079 |
Soggetto topico |
Oncology
Immunology Hematology |
ISBN | 3-030-30845-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Introduction on cancer immunology and immunotherapy -- Inflammatory and innate immune cells in cancer microenvironment and progression -- Role of innate immunity in cancers and antitumor response -- Role of B cells in anti tumor response -- The role of exhaustion in tumor-induced T cell dysfunction in patients with cancer -- Regulatory T cells and Th17 cells in the immunosuppressive tumor network -- Role of cytokines in tumor immunity and immune tolerance to cancers -- Role of chemokines and chemokine receptors in cancers -- The role of Fas and Fas-ligand in cancers -- MHC class I molecules and cancer progression: Lessons learned from preclinical tumor models -- Role of plasmacytoid dendritic cells in cancer -- Cancer immunoediting: immunosurveillance, immuneequilibrium, and immune escape -- Apoptosis, autophagy and necroptosis in Cancer -- Prognostic value of innate and adaptive immunity in cancers -- Epigenetics and Micro RNAs in cancers -- Immunogenetics of cancers -- Immunodeficiencies and cancers -- Immunosenescence and cancers -- Nutrition, immunity and cancers -- Allergies and cancers -- Cancer immunology of transmissible cancers -- Systems biology and systems immunology of cancer -- Principles of immunological diagnostic tests for cancers -- Flow cytometry in cancer immunotherapy: applications, analysis, quality control and future -- Immunohistochemistry of cancers -- Immunology and immunotherapy of graft versus host disease. . |
Record Nr. | UNINA-9910373947903321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Immune checkpoint inhibitors in cancer / / Fumito Ito, Marc S. Ernstoff |
Autore | Ito Fumito |
Pubbl/distr/stampa | St. Louis, Missouri : , : Elsevier, , [2019] |
Descrizione fisica | 1 online resource (513 pages) |
Disciplina | 616.994079 |
Soggetto topico | Cancer - Immunological aspects |
ISBN |
0-323-54950-0
0-323-54948-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Immune checkpoint inhibitors: mechanisms and emerging therapeutic opportunities -- Immune checkpoints: melanoma and other skin cancers -- The current status of immunotherapy in thoracic malignancies -- Immune checkpoint inhibitors in gastrointestinal malignancies -- Cancers of the head and neck -- Urologic malignancies -- Gynecologic malignancies -- Breast cancer -- Hematologic malignancies -- Pediatric malignancies -- Toxicities in immune checkpoint inhibitors -- Future of immune checkpoint inhibitors |
Record Nr. | UNINA-9910583389903321 |
Ito Fumito
![]() |
||
St. Louis, Missouri : , : Elsevier, , [2019] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunotherapy in translational cancer research / / edited by Laurence J. N. Cooper [and three others] |
Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley Blackwell, , 2018 |
Descrizione fisica | 1 online resource (309 pages) : illustrations (some color), tables |
Disciplina | 616.994079 |
Collana | Translational Oncology |
Soggetto topico |
Cancer - Immunotherapy
Cancer - Immunological aspects |
ISBN |
1-118-68452-4
1-118-68450-8 1-118-68453-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Translation in Immunology : the role of translational biomarkers to guide clinical use of immunotherapy for cancer / Saranya Chumsri and Keith L. Knutson -- Monoclonal antibody therapy / Elizabeth A. Mittendorf and Sabitha Prabhakaran -- Somatic mutations and immunotherapy / Eric Tran -- Checkpoint Blockade / Tracy A. Proverbs-Singh, Jedd Wolchok, and Alexandra Snyder -- Myeloid leukemia vaccines / Paul M. Armistead and Jonathan S. Serody -- Cancer vaccines for solid tumors / Timothy J. Vreeland, Garth S. Herbert, and George E. Peoples -- Immunotherapy with non-genetically modified T cells / Cassian Yee -- Immunotherapy with genetically modified T cells / Liora Schultz and Crystal Mackall -- Immunomodulation with adjuvants and cytokines / Dae won Kim and Adi Diab -- Immune cell migration in cancer and immunotherapy / Timothy Murray and Daniel E. Speiser -- Repurposing of drugs for immunotherapy / Jyothishmathi Swaminathan and Vidya Gopalakrishnan -- Immunomodulation with radiation / Jonathan E. Schoenhals, Taylor R. Cushman, Alexandra P. Cadena, Sandra Demaria, and James W. Welsh -- Good manufacturing practices facilities for cellular therapy / Andrew D. Fesnak and Bruce L. Levine -- T cell receptor mimic antibodies / Gheath Alatrash and Jeffrey J. Molldrem -- Stem cell transplantation for treatment of malignancy / Lohith S. Bachegowda and Richard E. Champlin -- Natural killer cell-based immunotherapy / Jennifer A. Foltz, Jeffrey S. Miller, and Dean A. Lee -- Immunologic monitoring in immuno-oncology / William R. Gwin and Mary L. Disis -- Cell-based therapies for canine cancer / Nicola J. Mason and M. Kazim Panjwani -- Interaction between targeted therapy and immunotherapy / Peter A. Prieto, Miles C. Andrews, Alexandria P. Cogdill, and Jennifer A. WargoInde. |
Record Nr. | UNINA-9910270869203321 |
Hoboken, New Jersey : , : Wiley Blackwell, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunotherapy in translational cancer research / / edited by Laurence J. N. Cooper [and three others] |
Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley Blackwell, , 2018 |
Descrizione fisica | 1 online resource (309 pages) : illustrations (some color), tables |
Disciplina | 616.994079 |
Collana | Translational Oncology |
Soggetto topico |
Cancer - Immunotherapy
Cancer - Immunological aspects |
ISBN |
1-118-68452-4
1-118-68450-8 1-118-68453-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Translation in Immunology : the role of translational biomarkers to guide clinical use of immunotherapy for cancer / Saranya Chumsri and Keith L. Knutson -- Monoclonal antibody therapy / Elizabeth A. Mittendorf and Sabitha Prabhakaran -- Somatic mutations and immunotherapy / Eric Tran -- Checkpoint Blockade / Tracy A. Proverbs-Singh, Jedd Wolchok, and Alexandra Snyder -- Myeloid leukemia vaccines / Paul M. Armistead and Jonathan S. Serody -- Cancer vaccines for solid tumors / Timothy J. Vreeland, Garth S. Herbert, and George E. Peoples -- Immunotherapy with non-genetically modified T cells / Cassian Yee -- Immunotherapy with genetically modified T cells / Liora Schultz and Crystal Mackall -- Immunomodulation with adjuvants and cytokines / Dae won Kim and Adi Diab -- Immune cell migration in cancer and immunotherapy / Timothy Murray and Daniel E. Speiser -- Repurposing of drugs for immunotherapy / Jyothishmathi Swaminathan and Vidya Gopalakrishnan -- Immunomodulation with radiation / Jonathan E. Schoenhals, Taylor R. Cushman, Alexandra P. Cadena, Sandra Demaria, and James W. Welsh -- Good manufacturing practices facilities for cellular therapy / Andrew D. Fesnak and Bruce L. Levine -- T cell receptor mimic antibodies / Gheath Alatrash and Jeffrey J. Molldrem -- Stem cell transplantation for treatment of malignancy / Lohith S. Bachegowda and Richard E. Champlin -- Natural killer cell-based immunotherapy / Jennifer A. Foltz, Jeffrey S. Miller, and Dean A. Lee -- Immunologic monitoring in immuno-oncology / William R. Gwin and Mary L. Disis -- Cell-based therapies for canine cancer / Nicola J. Mason and M. Kazim Panjwani -- Interaction between targeted therapy and immunotherapy / Peter A. Prieto, Miles C. Andrews, Alexandria P. Cogdill, and Jennifer A. WargoInde. |
Record Nr. | UNINA-9910824919903321 |
Hoboken, New Jersey : , : Wiley Blackwell, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunotherapy of Cancer [[electronic resource] ] : An Innovative Treatment Comes of Age / / edited by Yoshiyuki Yamaguchi |
Edizione | [1st ed. 2016.] |
Pubbl/distr/stampa | Tokyo : , : Springer Japan : , : Imprint : Springer, , 2016 |
Descrizione fisica | 1 online resource (351 p.) |
Disciplina | 616.994079 |
Soggetto topico |
Oncology
Cancer research Immunology Oncology Cancer Research |
ISBN | 4-431-55031-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Part I Overview, History, Classification -- Chapter 1 Overview of Current Cancer Immunotherapy -- Part II BRMs and Crude Agents -- Chapter 2 Bacterial Preparations -- Chapter 3 Polysaccharides -- Chapter 4 BCG -- Part III Cytokines -- Chapter 5 αβ-T Cells -- Chapter 6 NKT Cell-Based Immunotherapy -- Chapter 7 Natural Killer Cells -- Chapter 8 γδ T Cell-Based Cancer Immunotherapy -- Chapter 9 Genetically engineered T cells -- Part IV Vaccine Therapy -- Chapter 10 Peptide Vaccine -- Chapter 11 Personalized Peptide Vaccine -- Chapter 12 WT1 Peptide Vaccine for the Treatment of Malignancies -- Chapter 13 Protein vaccine -- Chapter 14 Dendritic Cell-Based Vaccine for Cancer -- Part V Immunoadjuvants -- Chapter 15 CpG Motif -- Chapter 16 Pattern Recognition by Dendritic Cells and Its Application to Vaccine Adjuvant for Antitumor Immunotherapy -- Chapter 17 Novel Adjuvants -- Part VI Immunocheckpoints -- Chapter 18 Anti-CTLA-4 Ab -- Chapter 19 Anti-PD-1, PD-L1 Ab -- Chapter 20 Novel Targets of Immune Inhibitory and Stimulatory Co-signals -- Part VII Regulation of Immunosuppression -- Chapter 21 Regulatory T Cells -- Chapter 22 MDSC: Myeloid-Derived Suppressor Cells -- Part VIII Immune-Related Response Criteria and Guidance for Clinical Trials -- Chapter 23 Immune-Related Response Criteria and Guidance for Clinical Trials -- Part IX Personalized Immunotherapy -- Chapter 24 ersonalized cancer immunotherapy: Immune biomarkers and combination immunotherapy. |
Record Nr. | UNINA-9910254558403321 |
Tokyo : , : Springer Japan : , : Imprint : Springer, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Inflammation and Cancer [[electronic resource] /] / edited by Bharat B. Aggarwal, Bokyung Sung, Subash Chandra Gupta |
Edizione | [1st ed. 2014.] |
Pubbl/distr/stampa | Basel : , : Springer Basel : , : Imprint : Springer, , 2014 |
Descrizione fisica | 1 online resource (488 p.) |
Disciplina | 616.994079 |
Collana | Advances in Experimental Medicine and Biology |
Soggetto topico |
Cancer research
Immunology Oncology Cancer Research Oncology |
ISBN | 3-0348-0837-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Inflammation and Lung Cancer -- Inflammation and Colon Cancer -- Inflammation and Breast Cancer -- Inflammation and Brain Cancer -- Inflammation and Head & Neck Cancer -- Inflammation and Pancreatic Cancer -- Inflammation and Prostate Cancer -- Inflammation and Bladder Cancer -- Inflammation and Renal Cancer -- Inflammation and Gastric Cancer -- Inflammation and Sarcoma -- Inflammation and Lymphoma -- Inflammation and Leukemia -- Inflammation and Multiple myeloma -- Inflammation and Cervical Cancer -- Inflammation and Liver Cancer -- Inflammation and Skin Cancer. |
Record Nr. | UNINA-9910298309803321 |
Basel : , : Springer Basel : , : Imprint : Springer, , 2014 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|